Factor | MRSA (n = 15) | Negative (n = 287) | Univariate analysis | Logistic regression (multivariate) | |||||
---|---|---|---|---|---|---|---|---|---|
OR (95%CI) | p | OR (95% CI) | p | ||||||
Male gender | 11 (73.3) | 129 (43.3) | 3.58 (1.11–11.51) | 0.02 | 3.64 (1.12–11.78) | 0.03 | |||
Age (median, quartiles) | 58 (46–73) | 63 (54–71) | – | 0.27 |  |  | |||
Time since diagnosis, years (median, quartiles) | 13 (10–19) | 15 (9–24) | – | 0.56 |  |  | |||
Use of insulin, years (median, quartiles) | 8 (3–15) | 7 (3–12) | – | 0.94 |  |  | |||
Diabetes type 2 | 11 (73.3) | 251 (84.5) | 0.50 (0.15–1.65) | 0.27 |  |  | |||
Heart disease | 3 (20.0) | 74 (25.8) | 0.72 (0.20–2.62) | 0.77 |  |  | |||
Lung disease | 0 | 33 (11.5) | – | 0.39 |  |  | |||
Kidney disease | 4 (26.7) | 78 (27.2) | 0.97 (0.30–3.15) | 1.00 |  |  | |||
Liver disease | 1 (6.7) | 26 (9.1) | 0.72 (0.09–5.67) | 1.00 |  |  | |||
CNS disease | 1 (6.7) | 49 (17.1) | 0.35 (0.04–2.70) | 0.48 |  |  | |||
Cancer | 2 (13.3) | 37 (12.7) | 1.06 (0.30–4.87) | 1.00 |  |  | |||
Trauma | 0 | 31 (10.8) | – | 0.38 |  |  | |||
Tattoo | 1 (6.7) | 15 (5.2) | 1.29 (0.16–10.52) | 0.57 |  |  | |||
lower-extremity ulcers | 3 (20.0) | 28 (9.8) | 2.31 (0.61–8.69) | 0.19 |  |  | |||
Amputation | 1 (6.7) | 9 (3.1) | 2.21 (0.26–18.65) | 0.40 |  |  | |||
Charlson comorbidity index ≥ 1 | 3 (2–4) | 3 (2–4) | – | 0.41 |  |  | |||
Hospitalization in the last year | 2 (13.3) | 46 (16.0) | 0.81 (0.18–3.69) | 1.00 |  |  | |||
Surgery in the last year | 3 (20.0) | 29 (10.1) | 2.22 (0.59–8.34) | 0.20 |  |  | |||
Antimicrobial use in the last year | 4 (26.7) | 74 (25.9) | 1.04 (0.32–3.37) | 1.00 |  |  |